Retatrutide Diarrhea: 34% Incidence — What Helps

Diarrhea was one of the most common side effects in the retatrutide Phase 2 trial, occurring in approximately 22-34% of patients depending on dose (Jastreboff et al., NEJM 2023). While this rate is higher than some other GLP-1 medications, the diarrhea is typically mild to moderate, occurs during dose escalation, and resolves as the GI tract adapts to the medication. Understanding the mechanism and management strategies can help patients navigate this common side effect.

Why Retatrutide Causes Diarrhea

GLP-1 receptor activation alters GI motility in complex ways. While it slows gastric emptying (keeping food in the stomach longer), it can accelerate transit through the lower GI tract. This altered motility can result in looser, more frequent stools, particularly during dose escalation when the GI tract is first adapting to the new hormonal signals.

The glucagon component in retatrutide may contribute additional GI effects. Glucagon receptor activation can stimulate bile acid secretion and alter water absorption in the intestines, both of which can contribute to diarrhea. This may explain why retatrutide's diarrhea rates are somewhat higher than pure GLP-1 agonists.

Diarrhea Rates by Dose

Management Strategies

Dietary Approaches

• BRAT diet during acute episodes: Bananas, rice, applesauce, toast — bland, binding foods that reduce stool frequency
• Reduce high-fat foods: Fat malabsorption contributes to loose stools
• Limit dairy: Lactose can worsen diarrhea, especially with altered GI motility
• Increase soluble fiber: Psyllium husk, oat fiber, and similar supplements can add bulk to stools
• Avoid artificial sweeteners: Sorbitol, mannitol, and other sugar alcohols can worsen diarrhea

Hydration and Electrolytes

Diarrhea increases fluid and electrolyte losses. Drink at least 8-10 glasses of water daily. Consider oral rehydration solutions or electrolyte drinks if episodes are frequent. Watch for signs of dehydration: dark urine, dizziness, dry mouth, or fatigue.

Over-the-Counter Options

Loperamide (Imodium) can be used for acute episodes but should not be used daily without physician guidance. Bismuth subsalicylate (Pepto-Bismol) may help mild cases. Probiotics may help restore gut microbiome balance during GI adaptation.

When to Seek Medical Attention

• More than 6 loose stools per day
• Blood or mucus in stool
• Diarrhea lasting more than 3 days without improvement
• Signs of dehydration despite adequate fluid intake
• Fever accompanying diarrhea (may indicate infection rather than medication effect)
• Severe abdominal cramping

The Good News: It Improves

In the Phase 2 trial, diarrhea was predominantly a dose-escalation phenomenon. The majority of patients who experienced diarrhea reported it during the first few weeks of a new dose, with significant improvement by week 4-6. Discontinuation due to diarrhea alone was uncommon, indicating that most patients found it manageable.

Get Support with Your Treatment

Trimi offers compounded semaglutide ($99/month) and compounded tirzepatide ($125/month) with ongoing medical support for side effect management including GI symptoms. Our providers can adjust dosing, recommend management strategies, and prescribe supportive medications when needed. Learn how Trimi works.

Frequently Asked Questions

How long does retatrutide diarrhea last?

Typically 1-4 weeks after starting or increasing dose. Most patients see significant improvement by week 4 at each dose level.

Is diarrhea more common with retatrutide than semaglutide?

Somewhat. Retatrutide's diarrhea rate (22-34%) is slightly higher than semaglutide's (~30%). The glucagon component may contribute additional GI effects.

Can probiotics help with retatrutide diarrhea?

Probiotics may help maintain gut microbiome balance during GI adaptation, though specific data with retatrutide is lacking. They are generally safe to take alongside GLP-1 medications.

Should I reduce my dose if diarrhea is severe?

Do not adjust your dose without consulting your healthcare provider. They may recommend holding at your current dose longer before the next increase, or temporarily reducing the dose if symptoms are severe.